We are live on ! Find out more
DCLA

Douglas C. Lane & Associates Portfolio holdings

AUM $3.69B
1-Year Est. Return 0.11%
This Fund
S&P 500
This Quarter Est. Return
-1.05%
1 Year Est. Return
+0.11%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.72B
AUM Growth
-$87M
Cap. Flow
-$14.7M
Cap. Flow %
-0.39%
Top 10 Hldgs %
20.24%
Holding
257
New
11
Increased
68
Reduced
140
Closed
22

Top Buys

Rank Stock Value
1
BKU icon
Bankunited
BKU
+$15.2M
2
SYF icon
Synchrony
SYF
+$9.24M
3
GCI
Gannett Co., Inc
GCI
+$7.03M
4
SSYS icon
Stratasys
SSYS
+$6.69M
5
JWN
Nordstrom
JWN
+$6.4M

Top Sells

Rank Stock Value
1
PLD icon
Prologis
PLD
+$27.9M
2
VC icon
Visteon
VC
+$14.8M
3
TGNA
TEGNA Inc
TGNA
+$6.92M
4
MDLZ icon
Mondelez International
MDLZ
+$6.73M
5
ABT icon
Abbott
ABT
+$6.68M

Sector Composition

Rank Sector Weight
1 Industrials 19.03%
2 Technology 15.24%
3 Healthcare 14.74%
4 Consumer Discretionary 12.34%
5 Financials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBD icon
151
Warner Bros
WBD
$66.2B
$878K 0.02%
26,399
-3,735
-12% -$123K
TWX
152
DELISTED
Time Warner Inc
TWX
$782K 0.02%
8,941
-851
-9% -$72.6K
CB
153
DELISTED
CHUBB CORPORATION
CB
$776K 0.02%
8,159
+25
+0.3% +$2.47K
MLM icon
154
Martin Marietta Materials
MLM
$32.3B
$764K 0.02%
5,402
+3,201
+145% +$467K
HD icon
155
Home Depot
HD
$349B
$744K 0.02%
6,694
-630
-9% -$70.5K
TDG icon
156
TransDigm Group
TDG
$69.8B
$709K 0.02%
3,156
CVS icon
157
CVS Health
CVS
$123B
$684K 0.02%
6,526
+296
+5% +$30.2K
HUB.A
158
DELISTED
HUBBELL INC CL-A
HUB.A
$680K 0.02%
6,307
-2,100
-25% -$236K
BAC icon
159
Bank of America
BAC
$441B
$653K 0.02%
38,374
+2,673
+7% +$44.1K
LUMN icon
160
Lumen
LUMN
$6.09B
$598K 0.02%
20,369
-1,909
-9% -$65K
KRFT
161
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$589K 0.02%
6,918
-920
-12% -$79.2K
ORCL icon
162
Oracle
ORCL
$413B
$583K 0.02%
14,458
+931
+7% +$40.4K
BA icon
163
Boeing
BA
$184B
$576K 0.02%
4,151
-855
-17% -$125K
KMB icon
164
Kimberly-Clark
KMB
$36.1B
$574K 0.02%
5,418
-219
-4% -$23.9K
LBTYK icon
165
Liberty Global Class C
LBTYK
$3.58B
$534K 0.01%
13,041
-1,617
-11% -$67K
ZBH icon
166
Zimmer Biomet
ZBH
$18.8B
$512K 0.01%
4,823
+253
+6% +$28K
BDX icon
167
Becton Dickinson
BDX
$48.8B
$498K 0.01%
3,601
+362
+11% +$50K
MCD icon
168
McDonald's
MCD
$196B
$498K 0.01%
5,234
+458
+10% +$44.3K
DD
169
DELISTED
Du Pont De Nemours E I
DD
$484K 0.01%
7,962
+147
+2% +$9.9K
BIIB icon
170
Biogen
BIIB
$30.5B
$479K 0.01%
1,187
-43
-3% -$17.3K
WBC
171
DELISTED
WABCO HOLDINGS INC.
WBC
$474K 0.01%
3,830
-800
-17% -$101K
UNH icon
172
UnitedHealth
UNH
$367B
$464K 0.01%
3,799
-303
-7% -$35.8K
TGT icon
173
Target
TGT
$66.8B
$439K 0.01%
5,373
+563
+12% +$45.6K
GEN icon
174
Gen Digital
GEN
$16.8B
$437K 0.01%
18,775
-31,336
-63% -$765K
NKE icon
175
Nike
NKE
$62.3B
$432K 0.01%
8,006
-1,056
-12% -$54.1K

Similar funds

Douglas C. Lane & Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Douglas C. Lane & Associates held 257 positions worth $3.72B, down 2.3% from $3.81B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Douglas C. Lane & Associates's Q2 2015 filing shows 11 new, 68 increased, 140 reduced and 22 closed positions. Its largest new stake was Gannett Co., Inc: 493,197 shares worth $6.9M. The largest sale was Prologis, an estimated $27.9M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Douglas C. Lane & Associates's largest Q2 2015 buy was Gannett Co., Inc: 493,197 shares worth $6.9M.
  • Douglas C. Lane & Associates added most to Bankunited in Q2 2015, an estimated $15.2M increase.
  • Douglas C. Lane & Associates's biggest Q2 2015 reduction was Prologis, cutting an estimated $27.9M.
  • Douglas C. Lane & Associates fully exited Magellan Midstream Partners, L.P. in Q2 2015, selling an estimated $384K.
  • Douglas C. Lane & Associates's ten largest holdings make up 20% of its $3.72B portfolio in Q2 2015.
  • Douglas C. Lane & Associates opened 11 new positions and closed 22 in Q2 2015.
  • Douglas C. Lane & Associates's portfolio value fell 2.3% quarter-over-quarter to $3.72B.

Based on Douglas C. Lane & Associates's 13F filing for Q2 2015, filed 21 Jul 2015.